Funded Tech Companies

Ajax Therapeutics

Researching who backed Ajax Therapeutics? Eli Lilly and Company, Schrodinger and Vivo Capital joined the equity holders in this biopharmaceutical company.

Company Overview

Company Name
Ajax Therapeutics
Company Status
Private & Independent
Funding Rounds

Contact Information

Mailing Address
275 Madison Ave. 39th floor
New York, NY 10016
USA
Email Address

Company Background Information

Overview
Advances in molecular genetics and biology have led to the development of new classes of targeted therapies for the treatment of hematologic malignancies. However, many of these therapies, while selective for a particular drug target, often interact with other related proteins which can limit their efficacy and lead to unwanted side effects.
Profile
Ajax Therapeutics LinkedIn Company Profile
Social Media
Ajax Therapeutics Company Twitter Account
Company News
Ajax Therapeutics News
Facebook
Ajax Therapeutics on Facebook
YouTube
Ajax Therapeutics on YouTube
Last Transaction
5/13/2024

Financing History

Date
Type
Amount
Venture Equity
$95,000,000
Venture Equity
$40,000,000


Management Team

Title
Name
Email & Social
Chief Executive Officer
Martin Vogelbaum
  Martin Vogelbaum LinkedIn Profile  Martin Vogelbaum Twitter Account  Martin Vogelbaum News  Martin Vogelbaum on Facebook
VP - R & D
Craig Masse
  Craig Masse LinkedIn Profile  Craig Masse Twitter Account  Craig Masse News  Craig Masse on Facebook


Company Investors

 

 

 

Browse more funded tech companies:

Ajax Health | Ajax Vascular

 

Share this article

 


About Our VC & M&A Database

This tech company profile is powered by VentureDeal.com, a leading supplier of venture capital funding data.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary